Why in News?
Recently, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) reached a significant milestone, with Janaushadhi medicines worth Rs. 1,000 crore sold in the year 2024-25 till October 2024.
Generic drugs are marketed under a non-proprietary or approved name rather than a proprietary or brand name. Generic drugs are equally effective and inexpensive compared to their branded counterparts.
Pharma & Medical Bureau of India (PMBI) was earlier called as Bureau of Pharma PSUs of India (BPPI).
Janaushadhi Kendras (JAKs) are accessible points for quality healthcare, providing a friendly environment where individuals can find the medications they need.